Skip to main content
SpringerLink
Log in

Malignant Germ Cell Tumors Metastatic to the Brain: A Model for a Curable Neoplasm? The Freiburg Experience and a Review of the Literature

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The aim of this study on malignant germ cell tumors metastasizing to the brain is (a) to report our institutional experience, (b) to present three patients surviving for more than seven years, and (c) to review the literature with regard to long-term survival.

From 1985 to 2000, 916 consecutive patients were treated with whole brain radiation therapy for brain metastases at our hospital. Eleven patients had cerebral lesions from histologically proven malignant germ cell tumors. Brain metastases were diagnosed at presentation (n = 2), following complete remission (n = 3), or along with extracerebral tumor progression (n = 6). Seven patients had a single brain metastasis. Three patients underwent resection. Eight patients reached the planned total dose of 50 Gy. Eight patients had chemotherapy.

Median survival was 6.6 months. The long-term survivors all had an isolated cerebral relapse after complete remission, presented with a single brain metastasis, and were treated with resection and whole brain radiation therapy to a total dose of 50 Gy. The first patient died from a late relapse 89 months after the diagnosis of brain metastasis, the second patient is well and alive at 95 months. The third patient is currently being treated for a second malignancy originating from the lung. He is alive at 194 months, the longest survival for brain metastases from malignant germ cell tumors ever reported.

Altogether, our study demonstrates that advanced extracerebral disease at initial diagnosis and isolated cerebral relapse after complete remission do not preclude long-term survival. Resection and whole brain radiation therapy might result in durable cerebral control with minimal morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37: 745–751, 1997

    Google Scholar 

  2. Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K: Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys 46: 297–302, 2000

    Google Scholar 

  3. Sanghavi SN, Saranarendra SM, Chappell R, Buatti JM, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Mabanta S, Mehta MP: Radiosurgery for patients with brain metastases: A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51: 426–434, 2001

    Google Scholar 

  4. Agboola O, Benoit B, Cross P, Da S, Esche B, Lesiuk H, Gonsalves C: Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 42: 155–159, 1998

    Google Scholar 

  5. Hall WA, Djalilian HR, Nussbaum ES, Cho KH: Long-term survival with metastatic cancer to the brain. Med Oncol 17: 279–286, 2000

    Google Scholar 

  6. Einhorn LH, Williams SD: Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer 46: 1339–1344, 1980

    Google Scholar 

  7. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316: 1435–1440, 1987

    Google Scholar 

  8. Einhorn EH: Testicular cancer: an oncological success story. Clin Cancer Res 3: 2630–2632, 1997

    Google Scholar 

  9. Anonymous: International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International germ cell cancer collaborative group. J Clin Oncol 15: 594-603, 1997

  10. Kaye SB, Begent RH, Newlands ES, Bagshawe KD: Successful treatment of malignant testicular teratoma with brain metastases. Br Med J 1: 233–234, 1979

    Google Scholar 

  11. Fossa SD, Bokemeyer C, Gerl A, Culine S, Jones WG, Mead GM, Germa L, Pont J, Schmoll HJ, Tjulandin S: Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 85: 988–997, 1999

    Google Scholar 

  12. Kaplan ES, Meier PJ: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958

    Google Scholar 

  13. Stolinsky DC: Prolonged survival after cerebral metastasis of testicular carcinoma. Cancer 47: 978–981, 1981

    Google Scholar 

  14. Feyerabend T, Wiedemann GJ, Steeves R: Advanced nonseminomatous germ cell cancer of the testis with brain metastases: feasibility of additional brain irradiation and whole body hyperthermia plus chemotherapy. Oncol Rep 8: 219–223, 2001

    Google Scholar 

  15. Logothetis CJ, Samuels ML, Trindade A: The management of brain metastases in germ cell tumors. Cancer 49: 12–18, 1982

    Google Scholar 

  16. Gerl A, Clemm C, Kohl P, Schalhorn A, Wilmanns W: Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer. Clin Exp Metast 12: 226–230, 1994

    Google Scholar 

  17. Rustin GJ, Newlands ES, Bagshawe KD, Begent RH, Crawford SM: Successful management of metastatic and primary germ cell tumors in the brain. Cancer 57: 2108–2113, 1986

    Google Scholar 

  18. Raghavan D, Mackintosh JF, Fox RM, Rogers J, Duval P, Besser M: Improved survival after brain metastases in nonseminomatous germ cell tumours with combined modality treatment. Br J Urol 60: 364–367, 1987

    Google Scholar 

  19. Jelsma RK, Carroll M: Brain metastasis from nonseminomatous germ cell tumors of the testis: case report and review of the role of surgery. Neurosurgery 25: 814–819, 1989

    Google Scholar 

  20. Spears WT, Morphis JG, Lester SG, Williams SD, Einhorn LH: Brain metastases and testicular tumors: longterm survival. Int J Radiat Oncol Biol Phys 22: 17–22, 1992

    Google Scholar 

  21. Mahalati K, Bilen CY, Ozen H, Aki FT, Kendi S: The management of brain metastasis in nonseminomatous germ cell tumours. BJU Int 83: 457–461, 1999

    Google Scholar 

  22. Salvati M, Cervoni L, Vitale AM, Raguso M, Caruso R, Delfini R: Solitary cerebral metastasis from tumor of the testis: some observations about treatment in two cases. Ital J Neurol Sci 18: 173–175, 1997

    Google Scholar 

  23. Suwa H, Hanakita J, Nishi S, Nishihara K, Ohta F, Sakaida H, Iihara K: Complete remission of metastatic teratoma from malignant testicular tumor using salvage chemotherapy with VP-16 (etoposide), CDDP, and ACNU-case report. Neurol Med Chir (Tokyo) 31: 277–282, 1991

    Google Scholar 

  24. Perry JJ, Jelinek JS: Isolated central nervous system relapse of testicular cancer. Med Pediatr Oncol 20: 68–70, 1992

    Google Scholar 

  25. Saiki S, Kinouchi T, Usami M, Nakagawa H, Kotake T: Glioblastoma multiforme after radiotherapy for metastatic brain tumor of testicular cancer. Int J Urol 4: 527–529, 1997

    Google Scholar 

  26. Vugrin D, Cvitkovic E, Posner J, Hajdu S, Golbey RB: Neurological complications of malignant germ cell tumors of testis: biology of brain metastases (I). Cancer 44: 2349–2353, 1979

    Google Scholar 

  27. Kaye SB, Bagshawe KD, McElwain TJ, Peckham MJ: Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers. Br J Cancer 39: 217–223, 1979

    Google Scholar 

  28. Bokemeyer C, Nowak P, Haupt A, Metzner B, Kohne H, Hartmann JT, Kanz L, Schmoll HJ: Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 15: 1449–1454, 1997

    Google Scholar 

  29. Einhorn LH, Williams SD: Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer 46: 1339–1344, 1980

    Google Scholar 

  30. Noordijk EM, Vecht CJ, Haaxma R, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR: The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 29: 711–717, 1994

    Google Scholar 

  31. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494–500, 1990

    Google Scholar 

  32. Athanassiou A, Begent RH, Newlands ES, Parker D, Rustin GJ, Bagshawe KD: Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital. Cancer 52: 1728–1735, 1983

    Google Scholar 

  33. Jakob A, Kollmannsberger C, Kanz L, Bokemeyer C: Late toxicity after chemotherapy of malignant testicular tumors. Urologe A 37: 635–647, 1998

    Google Scholar 

  34. Crossen JR, Garwood D, Glatstein E, Neuwelt EA: Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12: 627–642, 1994

    Google Scholar 

  35. Lester SG, Morphis JG, Hornback NB, Williams SD, Einhorn LH: Brain metastases and testicular tumors: need for aggressive therapy. J Clin Oncol 2: 1397–1403, 1984

    Google Scholar 

  36. Travis LB, Andersson M, Gospodarowicz M, van L, Bergfeldt K, Lynch CF, Curtis RE, Kohler BA, Wiklund T, Storm H, Holowaty E, Hall P, Pukkala E, Sleijfer DT, Clarke EA, Boice JD, Stovall M, Gilbert E: Treatmentassociated leukemia following testicular cancer. J Natl Cancer Inst 92: 1165–1171, 2000

    Google Scholar 

  37. Bower M, Newlands ES, Holden L, Rustin GJ, Begent RH: Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy. Ann Oncol 8: 477–483, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Freiburg, Freiburg i. Br., Germany

    Johannes Lutterbach & Susanne Bartelt

  2. Department of Neurosurgery, University of Freiburg, Freiburg i. Br., Germany

    Uwe Spetzger

  3. Department of Neuropathology, University of Freiburg, Freiburg i. Br., Germany

    Axel Pagenstecher

Authors
  1. Johannes Lutterbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uwe Spetzger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susanne Bartelt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Axel Pagenstecher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lutterbach, J., Spetzger, U., Bartelt, S. et al. Malignant Germ Cell Tumors Metastatic to the Brain: A Model for a Curable Neoplasm? The Freiburg Experience and a Review of the Literature. J Neurooncol 58, 147–156 (2002). https://doi.org/10.1023/A:1016009432387

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016009432387

Search

Navigation